Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.74 USD | -2.68% | -3.25% | +28.39% |
04-30 | Citigroup Adjusts Price Target on Owens & Minor to $28 From $24, Maintains Neutral Rating | MT |
04-10 | Baird Raises Owens & Minor's Price Target to $28 From $24, Maintains Neutral Rating | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company shows low valuation levels, with an enterprise value at 0.33 times its sales.
- The company has a low valuation given the cash flows generated by its activity.
- For the past twelve months, EPS forecast has been revised upwards.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 164.93 times its estimated earnings per share for the ongoing year.
- The company is not the most generous with respect to shareholders' compensation.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+28.39% | 1.9B | B+ | ||
-8.49% | 8.9B | B+ | ||
-2.74% | 1.41B | D | ||
-7.86% | 1.19B | - | ||
-16.38% | 878M | - | - | |
+1.00% | 470M | - | ||
+3.05% | 435M | - | - | |
-47.25% | 377M | - | ||
-22.11% | 345M | - | - | |
-34.72% | 191M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- OMI Stock
- Ratings Owens & Minor, Inc.